BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29326053)

  • 1. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumour Cells in Lung Cancer.
    Chemi F; Mohan S; Brady G
    Recent Results Cancer Res; 2020; 215():105-125. PubMed ID: 31605226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical indications for, and the future of, circulating tumor cells.
    Moon DH; Lindsay DP; Hong S; Wang AZ
    Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor Cells: High-Throughput Imaging of CTCs and Bioinformatic Analysis.
    Keomanee-Dizon K; Shishido SN; Kuhn P
    Recent Results Cancer Res; 2020; 215():89-104. PubMed ID: 31605225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells.
    Paoletti C; Hayes DF
    Adv Exp Med Biol; 2016; 882():235-58. PubMed ID: 26987538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of CTCs as Tumor Biomarkers.
    Lianidou ES; Markou A; Strati A
    Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling circulating tumour cells and other biomarkers of invasive cancers.
    Poudineh M; Sargent EH; Pantel K; Kelley SO
    Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using circulating tumor cells to inform on prostate cancer biology and clinical utility.
    Li J; Gregory SG; Garcia-Blanco MA; Armstrong AJ
    Crit Rev Clin Lab Sci; 2015; 52(4):191-210. PubMed ID: 26079252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in prostate cancer: beyond enumeration.
    Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.